NASDAQ · Medical - Healthcare Information Services

HCAT (HCAT) Stock

$2.16 +0.93% NASDAQ: HCAT Healthcare

Valuation

MetricValue
Price$2.16
Market Cap$159.61M
P/E Ratio-0.54
P/B Ratio0.41
P/S Ratio0.42
EPS (TTM)$-2.55
52-Week High$4.13
52-Week Low$0.95
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-72.36%
ROA-35.39%
ROCE-14.63%
Gross Margin-11.58%
Operating Margin-11.58%
Net Margin-87.69%
Debt/Equity1.23
Current Ratio1.88

Annual Financials (USD)

Metric20212022202320242025
Revenue$242.0M$276.0M$296.0M$307.0M$311.0M
Operating Profit$-144.0M$-140.0M$-127.0M$-70.0M$-36.0M
Net Profit$-153.0M$-137.0M$-118.0M$-70.0M$-178.0M
EPS$-3.23$-2.54$-2.09$-1.15$-2.55
Op Margin-59.4%-50.7%-42.9%-22.8%-11.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$832.0M$752.0M$702.0M$859.0M$503.0M
Total Liabilities$310.0M$327.0M$335.0M$494.0M$257.0M
Cash$193.0M$116.0M$106.0M$250.0M$51.0M
Borrowings$205.0M$248.0M$249.0M$402.0M$171.0M

Latest News

3 Reasons to Sell HCAT and 1 Stock to Buy Instead StockStory · Jul 15, 2026 3 Small-Cap Stocks We Think Twice About StockStory · Jul 13, 2026 monday.com, Intuit, and Health Catalyst Stocks Trade Down, What You Need To Know StockStory · Jul 8, 2026 3 Stocks Under $10 We’re Skeptical Of StockStory · Jul 3, 2026 Health Catalyst, PubMatic, and PTC Stocks Trade Up, What You Need To Know StockStory · Jul 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-23.0M$-35.0M$-33.0M$15.0M$1.0M
Investing Cash Flow$-158.0M$-56.0M$6.0M$-39.0M$35.0M
Financing Cash Flow$19.0M$-3.0M$3.0M$-2.0M$-5.0M
Net Cash Flow$101.0M$-77.0M$-10.0M$143.0M$-199.0M
Free Cash Flow$-42.0M$-53.0M$-47.0M$-2.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA16.47
FCF Yield7.21%
Quick Ratio1.69
Interest Coverage-2.25
Return 1Y-40.67%
Return 3Y-81.38%
Return 5Y-95.82%

Ownership

Insiders Held5.15%
Institutions Held78.11%
Institutions Float Held82.35%
Institutional HolderSharesReport Date
First Light Asset Management, LLC12,878,7002026-03-31
Cdc Financial, Inc.6,307,0542026-03-31
Blackrock Inc.5,138,0222026-03-31
Whetstone Capital Advisors, LLC4,268,1412026-03-31
Nepsis, Inc.2,976,1872026-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CRBU $1.65 +0.61% -1.25 $163.65M 0.00%
ENTA $12.61 -0.94% -6.04 $366.68M 0.00%
HSDT $1.69 +0.60% -1.25 $98.67M 0.00%
NNOX $1.06 +3.92% -1.56 $73.78M 0.00%
OBIO $3.86 +1.05% -3.70 $231.14M 0.00%

About HCAT

HCAT is led by CEO Benjamin Albert, employs 1,500 people, headquartered in US, publicly traded since 2019.

HCAT stock trades at $2.16 with a market capitalization of $159.61M. The stock is valued at a price-to-earnings (P/E) ratio of -0.54, price-to-book of 0.41, price-to-sales of 0.42. Over the past 52 weeks the stock has ranged between $0.95 and $4.13, and currently trades 47.6% below its 52-week high.

On profitability, HCAT generates a return on equity (ROE) of -72.36%, return on capital employed of -14.63%, an operating margin of -11.58%, a net profit margin of -87.69%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides